Muralidhar R. Mallireddigari

Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity

Natala Srinivasa Reddy, Muralidhar R. Mallireddigari, Stephen C. Cosenza et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 164 citations

Medicinal Chemistry, Derivative (Chemistry), Natural Sciences +8

Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors

M. V. Ramana Reddy, Vinay K. Billa, Venkat R. Pallela et al. · Bioorganic & Medicinal Chemistry · 2008 · 113 citations · Full text

Medicinal Chemistry, -3-Trifluoromethyl-5-indolyl Pyrazolines, Pharmaceutical Science +11

Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (<i>E</i>)-2-{2-Methoxy-5-[(2′,4′,6′-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure–Activity Relationship, and Biological Activity

M. V. Ramana Reddy, V. Padmavathi, Muralidhar R. Mallireddigari et al. · Journal of Medicinal Chemistry · 2011 · 94 citations · Full text

Structure–activity Relationship, Pharmaceutical Science, Cyclin D Proteins +20

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-<i>d</i>]pyrimidine-6-carbonitrile (<b>7x</b>) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)

M. V. Ramana Reddy, Balireddy Akula, Stephen C. Cosenza et al. · Journal of Medicinal Chemistry · 2014 · 70 citations · Full text

Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1

Natala Srinivasa Reddy, Kiranmai Gumireddy, Muralidhar R. Mallireddigari et al. · Bioorganic & Medicinal Chemistry · 2005 · 60 citations

Novel Coumarin-3-, Breast Oncology, Medicine +9